A5033964668- Nuclear Physics and Applications
- Magnetic confinement fusion research
- Engineering Applied Research
- RNA Research and Splicing
- Optical Systems and Laser Technology
- Nanoplatforms for cancer theranostics
- Fusion materials and technologies
- Cancer Immunotherapy and Biomarkers
- Laser-Plasma Interactions and Diagnostics
- Nuclear Materials and Properties
- Power Systems and Renewable Energy
- RNA modifications and cancer
- Immunotherapy and Immune Responses
- Silicon and Solar Cell Technologies
- RNA and protein synthesis mechanisms
- Boron Compounds in Chemistry
- Laser-induced spectroscopy and plasma
- Iterative Learning Control Systems
ENN (China)
2024
Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University
2024
Wenzhou Medical University
2024
Brigham and Women's Hospital
2014
Harvard University
2014
ENN Science and Technology Development Co., Ltd. (ENN) is committed to generating fusion energy in an environmentally friendly cost-effective manner, which requires abundant aneutronic fuel. Proton-boron (p-11B or p-B) considered ideal choice for this purpose. Recent studies have suggested that p-B fusion, although challenging, feasible based on new cross section data, provided a hot ion mode high wall reflection can be achieved reduce electron radiation loss. The beta good confinement of...
Abstract ENN He Long-2 (EHL-2) is the next-generation large Mega-Ampere (MA) spherical torus (ST) proposed and funded by company. The design parameters are: T i0 > 30 keV, n e0 ~1×10 20 m -3 , I p ~ 3 MA, B t T. How to achieve several MA current flat-top with limited voltage-second ( Vs ) of center solenoid (CS) coils one most challenges issue EHL-2. In order minimize consumption Vs, fully non-inductive start-up ECRH will be applied in ramp-up phase accomplished synergetic mode between CS...
XuanLong-50 (EXL-50) is the first medium-size spherical torus (ST) in China, with toroidal field at major radius 50 cm around 0.5T. CS-free and non-inductive current drive via electron cyclotron resonance heating (ECRH) was main physics research issue for EXL-50. Discharges plasma currents of kA - 180 were routinely obtained EXL-50, flattop sustained up to or beyond 2 s. The effectiveness on EXL-50 as high 1 A/W low-density discharges using 28GHz ECRH alone power less than 200 kW. reached...
ENN Science and Technology Development Co., Ltd. (ENN) is committed to generating fusion energy in an environmentally friendly cost-effective manner, which requires abundant aneutronic fuel. Proton-boron ( p-$^{11}$B or p-B) considered ideal choice for this purpose. Recent studies have suggested that p-B fusion, although challenging, feasible based on new cross-section data, provided a hot ion mode high wall reflection can be achieved reduce electron radiation loss. The beta good confinement...
Chemoimmunotherapy has the potential to enhance chemotherapy and modulate immunosuppressive tumor microenvironment by activating immunogenic cell death (ICD), making it a promising strategy for clinical application. Alantolactone (A) was found augment anticancer efficacy of paclitaxel (P) at molar ratio 1:0.5 (P:A) through induction more potent ICD via modulation STAT3 signaling pathways. Nano drug delivery systems can synergistically combine natural drugs with conventional chemotherapeutic...
Abstract ENN is planning the next generation experimental device EHL-2 with goal to verify thermal reaction rates of p-11B fusion, establish spherical torus/tokamak scaling laws at 10's keV ion temperature, and provide a design basis succeeding experiment aiming test achieve fusion burning plasma. Based on 0-dimential system 1.5-dimentional transport modelling analyses, main target parameters have been basically determined, including plasma major radius, R0, 1.05 m, aspect ratio, A, 1.85,...